ATAI Life Sciences N.V.

Insider Reports History

Entity
Company
Location
Wallstrasse 16, Berlin, Germany
Signature
ATAI Life Sciences N.V., By: /s/ Florian Brand, Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ATAI Life Sciences N.V.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
COMPASS Pathways plc 10%+ Owner Ordinary Shares 9.57M $79.9M $8.35 Jan 1, 2022 By ATAI Life Sciences AG
IntelGenx Technologies Corp. 10%+ Owner Warrant (Right to Buy) 4M Mar 8, 2024 By ATAI Life Sciences AG
IntelGenx Technologies Corp. 10%+ Owner Convertible Promissory Note 2.97M Nov 28, 2023 By ATAI Life Sciences AG
IntelGenx Technologies Corp. 10%+ Owner Call Option (Right to Buy) 7.4K Sep 30, 2023 By ATAI Life Sciences AG
IntelGenx Technologies Corp. 10%+ Owner Convertible Notes $10.5M Apr 19, 2024 By ATAI Life Sciences AG

Insider Reports Filed by ATAI Life Sciences N.V.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IGXT IntelGenx Technologies Corp. Apr 19, 2024 1 $1M 4 May 3, 2024 10%+ Owner
IGXT IntelGenx Technologies Corp. Sep 30, 2023 6 $0 4 Mar 12, 2024 10%+ Owner
IGXT IntelGenx Technologies Corp. Aug 31, 2023 2 $2.22M 4 Sep 5, 2023 10%+ Owner
CMPS COMPASS Pathways plc Jan 1, 2022 0 $0 3 Feb 28, 2022 10%+ Owner
IGXT IntelGenx Technologies Corp. May 14, 2021 0 $0 3 May 24, 2021 10%+ Owner